Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate

NCT01354301 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infection
Renal Transplant Failure
Transplant; Complication, Rejection

Interventions

DRUG: Thymoglobulin
DRUG: Everolimus
DRUG: Basiliximabe
DRUG: mycophenolate sodium
DRUG: Tacrolimus
DRUG: Tacrolimus
DRUG: Tacrolimus

Sponsor

Hospital do Rim e Hipertensão